fb pixel

Hydrocodone Combination Products (HCP) reclassified from Schedule III to Schedule II Drugs

Table of Contents

Drug Schedules HCP document with waismann method logo

Effective October 6, 2014, hydrocodone combination products (HCP), such as Vicodin and Lortab, have been reclassified from Schedule III to Schedule II drugs. This means doctors can no longer phone in a prescription for HCP’s and that patients must present a written prescription to the pharmacist.
View our PDF of the HCP reclassification.

More To Explore

Suboxone Addiction and Its Impact on Families

Suboxone, a combination of buprenorphine and naloxone, has been widely used as a medication to treat opioid addiction. While its role in opioid replacement therapy is well-recognized, the potential...